Christopher Mirabelli's Net Worth
Estimate Recalculated Nov 1, 2024 02:24PM EST
Who is Christopher Mirabelli
Christopher Mirabelli does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PHARMATHENE, INC, REPLIDYNE INC, CRITICAL THERAPEUTICS INC, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, LEAP THERAPEUTICS, INC., TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, and MEMORY PHARMACEUTICALS CORP.
SEC CIK
Christopher Mirabelli's CIK is 0001262326
Past Insider Trading and Trends
2021 was Christopher Mirabelli's most active year for acquiring shares with 3 total transactions. Christopher Mirabelli's most active month to acquire stocks was the month of December. 2021 was Christopher Mirabelli's most active year for disposing of shares, totalling 1 transactions. Christopher Mirabelli's most active month to dispose stocks was the month of December. 2023 saw Christopher Mirabelli paying a total of $0.00 for 570,000 shares, this is the most they've acquired in one year. In 2021 Christopher Mirabelli cashed out on 571,428 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
